Health and Fitness Health and Fitness
Tue, January 13, 2009
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Thu, January 8, 2009
Wed, January 7, 2009
Tue, January 6, 2009
Mon, January 5, 2009
[ Mon, Jan 05th 2009 ] - Market Wire
Avexa and Progen Merger Update
Fri, January 2, 2009
Thu, January 1, 2009
Wed, December 31, 2008
[ Wed, Dec 31st 2008 ] - Market Wire
Obesity Comes With a Price Tag
Tue, December 30, 2008
Mon, December 29, 2008
Wed, December 24, 2008
Tue, December 23, 2008
Mon, December 22, 2008

The Medicines Company: The Medicines Company to Participate in the 27th Annual JP Morgan Healthcare Conference


Published on 2009-01-06 14:45:50, Last Modified on 2009-01-06 14:46:11 - Market Wire
  Print publication without navigation


PARSIPPANY, NJ--(Marketwire - January 6, 2009) - The Medicines Company (NASDAQ: [ MDCO ]) is scheduled to participate in the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13th, at 9am Pacific Time, 12:00pm Eastern Time. A company overview and outlook will be provided in the presentation.

The session will be webcast with a link available at The Medicines Company's website: [ http://www.themedicinescompany.com ].

MDCO-G

About The Medicines Company

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU-2010, in early-stage development. The Company's website is [ www.themedicinescompany.com ].


Publication Contributing Sources

Similar Health and Fitness Publications